DIRECTO, the B2B platform servicing the pharmacy sector supply chain, has extended its $3 million capital raise deadline due to "strong interest" from many pharmacists who are keen to invest directly (PD 21 Jun).
Fully paid ordinary shares are being offered at $3.26 per share, with the offer closing on 31 Jul.
The move allows pharmacists to take a financial stake in Directo, enabling them to contribute to and benefit from significant changes in the pharmacy sector.
Founder Gavin Upiter (pictured)said, "the Directo platform is designed for the pharmacy sector by industry experts".
"Our networked two-sided online marketplace integrates into pharmacy enterprise solutions and addresses the needs of retail pharmacies and their suppliers by reducing administrative time."
Directo aims to streamline the fragmented Australian pharmacy industry and is already serving TerryWhite Chemmart and Chempro.
It connects over 3,000 pharmacies with 180 suppliers, offering 30,000 multi-category products from brands such as McPherson's, Aero Healthcare, Nude by Nature, The Jojoba Company, Gibsons Eyewear, and Gibson Gifts.
"The digitised supply chain platform enhances processes by reducing costs, boosting efficiency, providing price transparency, and simplifying interactions," commented Upiter.
With 54% of Australian pharmacies already using the platform and revenue doubling in the past two years, the capital raise will support Directo's growth and fund the integration of advanced AI for task management, phone, and analytics tools.
This technological upgrade aims to enhance user experience, streamline operations, and drive further adoption of the platform. JG
To register interest, CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Jul 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Jul 24
